Phibro Animal Health | PAHC - Des Atouts





Des Atouts Changement Date
Align Technology USD 6.42B 103.41M 2026-06
ANI Pharmaceuticals USD 1.49B 72.14M 2026-06
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Canopy Growth CAD 1.12B 12.54M 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Henry Schein USD 11.38B 77M 2026-06
Idexx Laboratories USD 3.44B 56.84M 2026-06
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Merck USD 129.8B 1.12B 2026-06
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Pacira USD 1.24B 35.44M 2026-06
Phibro Animal Health USD 1.45B 39.56M 2026-03
Prestige Brands USD 4.57B 1.07B 2026-06
Supernus Pharmaceuticals USD 1.43B 72.62M 2026-06
Zoetis USD 15.08B 77M 2026-06